|
1
|
Conyers R, Young S and Thomas DM:
Liposarcoma: Molecular genetics and therapeutics. Sarcoma.
2011:4831542010.PubMed/NCBI
|
|
2
|
De Vita A, Mercatali L, Recine F, Pieri F,
Riva N, Bongiovanni A, Liverani C, Spadazzi C, Miserocchi G,
Amadori D and Ibrahim T: Current classification, treatment options,
and new perspectives in the management of adipocytic sarcomas. Onco
Targets Ther. 9:6233–6246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Moreau LC, Turcotte R, Ferguson P, Wunder
J, Clarkson P, Masri B, Isler M, Dion N, Werier J, Ghert M, et al:
Myxoidround cell liposarcoma (MRCLS) revisited: An analysis of 418
primarily managed cases. Ann Surg Oncol. 19:1081–1088. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Haniball J, Sumathi VP, Kindblom LG, Abudu
A, Carter SR, Tillman RM, Jeys L, Spooner D, Peake D and Grimer RJ:
Prognostic factors and metastatic patterns in primary
myxoid/round-cell liposarcoma. Sarcoma. 2011:5380852011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hoffman A, Ghadimi MP, Demicco EG,
Creighton CJ, Torres K, Colombo C, Peng T, Lusby K, Ingram D,
Hornick JL, et al: Localized and metastatic myxoid/round cell
liposarcoma: Clinical and molecular observations. Cancer.
119:1868–1877. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fiore M, Grosso F, Lo Vullo S,
Pennacchioli E, Stacchiotti S, Ferrari A, Collini P, Lozza L,
Mariani L, Casali PG and Gronchi A: Myxoid/round cell and
pleomorphic liposarcomas: Prognostic factors and survival in a
series of patients treated at a single institution. Cancer.
109:2522–2531. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zheng K, Yu XC, Xu M and Yang Y: Surgical
outcomes and prognostic factors of myxoid liposarcoma in
extremities: A retrospective study. Orthop Surg. 11:1020–1028.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Higgins JP, Altman DG, Gøtzsche PC, Jüni
P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, et
al: The cochrane collaboration's tool for assessing risk of bias in
randomised trials. BMJ. 343:d59282011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wells GA, Shea B, O'Connell D, Peterson J,
Welch V, Losos M and Tugwell P: The Newcastle-Ottawa scale (NOS)
for assessing the quality of non-randomized studies in
meta-analysis. 2000.
|
|
10
|
Dürr HR, Rauh J, Baur-Melnyk A, Knösel T,
Lindner L, Roeder F, Jansson V and Klein A: Myxoid liposarcoma:
local relapse and metastatic pattern in 43 patients. BMC Cancer.
18:3042018. View Article : Google Scholar
|
|
11
|
Wu J, Qian S and Jin L: Prognostic factors
of patients with extremity myxoid liposarcomas after surgery. J
Orthop Surg Res. 14:902019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nishida Y, Tsukushi S, Nakashima H and
Ishiguro N: Clinicopathologic prognostic factors of pure myxoid
liposarcoma of the extremities and trunk wall. Clin Orthop Relat
Res. 468:3041–3046. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lansu J, Bovée JVMG, Braam P, van Boven H,
Flucke U, Bonenkamp JJ, Miah AB, Zaidi SH, Thway K, Bruland ØS, et
al: Dose reduction of preoperative radiotherapy in myxoid
liposarcoma: A nonrandomized controlled trial. JAMA Oncol.
7:e2058652021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Greto D, Saieva C, Loi M, Terziani F,
Visani L, Garlatti P, Lo Russo M, Muntoni C, Becherini C, Topulli
J, et al: Influence of age and subtype in outcome of operable
liposarcoma. Radiol Med. 124:290–300. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kilpatrick SE, Doyon J, Choong PF, Sim FH
and Nascimento AG: The clinicopathologic spectrum of myxoid and
round cell liposarcoma. A study of 95 cases. Cancer. 77:1450–1458.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cohen HJ: Biology of aging as related to
cancer. Cancer. 74.(7 Suppl):S2092–S2100. 1994.
|
|
17
|
ten Heuvel SE, Hoekstra HJ, van Ginkel RJ,
Bastiaannet E and Suurmeijer AJ: Clinicopathologic prognostic
factors in myxoid liposarcoma: A retrospective study of 49 patients
with long-term follow-up. Ann Surg Oncol. 14:222–229. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Antonescu CR, Tschernyavsky SJ, Decuseara
R, Leung DH, Woodruff JM, Brennan MF, Bridge JA, Neff JR, Goldblum
JR and Ladanyi M: Prognostic impact of P53 status, TLS-CHOP fusion
transcript structure, and histological grade in myxoid liposarcoma:
A molecular and clinicopathologic study of 82 cases. Clin Cancer
Res. 7:3977–3987. 2001.PubMed/NCBI
|
|
19
|
Smith TA, Easley KA and Goldblum JR:
Myxoid/round cell liposarcoma of the extremities. A
clinicopathologic study of 29 cases with particular attention to
extent of round cell liposarcoma. Am J Surg Pathol. 20:171–180.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Callegaro D, Miceli R, Bonvalot S,
Ferguson PC, Strauss DC, van Praag VVM, Levy A, Griffin AM, Hayes
AJ, Stacchiotti S, et al: Development and external validation of a
dynamic prognostic nomogram for primary extremity soft tissue
sarcoma survivors. EClinicalMedicine. 17:1002152019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gustafson P: Soft tissue sarcoma:
Epidemiology and prognosis in 508 patients. Acta Orthop Scand
Suppl. 259:2–31. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chang HR, Hajdu SI, Collin C and Brennan
MF: The prognostic value of histologic subtypes in primary
extremity liposarcoma. Cancer. 64:1514–1520. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kilpatrick SE, Ward WG and Bos GD: The
value of fine-needle aspiration biopsy in the differential
diagnosis of adult myxoid sarcoma. Cancer. 90:167–177. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Evans HL: Liposarcoma a study of 55 cases
with a reassessment of its classification. Am J Surg Pathol.
3:507–523. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fiore M, Ford S, Callegaro D, Sangalli C,
Colombo C, Radaelli S, Frezza AM, Renne SL, Casali PG and Gronchi
A: Adequate local control in high-risk soft tissue sarcoma of the
extremity treated with surgery alone at a reference centre: Should
radiotherapy still be a standard? Ann Surg Oncol. 25:1536–1543.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Spillane AJ, Fisher C and Thomas JM:
Myxoid liposarcoma-the frequency and the natural history of
nonpulmonary soft tissue metastases. Ann Surg Oncol. 6:389–394.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lemeur M, Mattei JC, Souteyrand P,
Chagnaud C, Curvale G and Rochwerger A: Prognostic factors for the
recurrence of myxoid liposarcoma: 20 cases with up to 8 years
follow-up. Orthop Traumatol Surg Res. 101:103–107. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bartlett EK, Curtin CE, Seier K, Qin LX,
Hameed M, Yoon SS, Crago AM, Brennan MF and Singer S: Histologic
subtype defines the risk and kinetics of recurrence and death for
primary extremity/truncal liposarcoma. Ann Surg. Jul 5–2019.(Epub
ahead of print). PubMed/NCBI
|
|
29
|
Yang JC, Chang AE, Baker AR, Sindelar WF,
Danforth DN, Topalian SL, DeLaney T, Glatstein E, Steinberg SM,
Merino MJ and Rosenberg SA: Randomized prospective study of the
benefit of adjuvant radiation therapy in the treatment of soft
tissue sarcomas of the extremity. J Clin Oncol. 16:197–203. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pisters P, Harrison LB, Leung D, Woodruff
JM, Casper ES and Brennan MF: Long-term results of a prospective
randomized trial of adjuvant brachytherapy in soft tissue sarcoma.
J Clin Oncol. 14:859–868. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Harrison LB, Franzese F, Gaynor JJ and
Brennan MF: Long-term results of a prospective randomized trial of
adjuvant brachytherapy in the management of completely resected
soft tissue sarcomas of the extremity and superficial trunk. Int J
Radiat Oncol Biol Phys. 27:259–265. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kattan MW, Leung DH and Brennan MF:
Postoperative nomogram for 12-year sarcoma-specific death. J Clin
Oncol. 20:791–796. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Orson GG, Sim FH, Reiman HM and Taylor WF:
Liposarcoma of the musculoskeletal system. Cancer. 60:1362–1370.
1987. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Reitan JB, Kaalhus O, Brennhovd IO, Sager
EM, Stenwig AE and Talle K: Prognostic factors in liposarcoma.
Cancer. 55:2482–2490. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Beane JD, Yang JC, White D, Steinberg SM,
Rosenberg SA and Rudloff U: Efficacy of adjuvant radiation therapy
in the treatment of soft tissue sarcoma of the extremity: 20-year
follow-up of a randomized prospective trial. Ann Surg Oncol.
21:2484–2489. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Engström K, Bergh P, Cederlund CG,
Hultborn R, Willen H, Aman P, Kindblom LG and Meis-Kindblom JM:
Irradiation of myxoid/round cell liposarcoma induces volume
reduction and lipoma-like morphology. Acta Oncol. 46:838–845. 2007.
View Article : Google Scholar
|
|
37
|
Knebel C, Lenze U, Pohlig F, Lenze F,
Harrasser N, Suren C, Breitenbach J, Rechl H, von Eisenhart-Rothe R
and Mühlhofer HML: Prognostic factors and outcome of liposarcoma
patients: A retrospective evaluation over 15 years. BMC Cancer.
17:4102017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
le Grange F, Cassoni A and Seddon B:
Tumour volume changes following pre-operative radiotherapy in
borderline resectable limb and trunk soft tissue sarcoma. Eur J
Surg Oncol. 40:394–401. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Guadagnolo BA, Zagars GK, Ballo MT, Patel
SR, Lewis VO, Benjamin RS and Pollock RE: Excellent local control
rates and distinctive patterns of failure in myxoid liposarcoma
treated with conservation surgery and radiotherapy. Int J Radiat
Oncol Biol Phys. 70:760–765. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Oh YJ, Yi SY, Kim KH, Cho YJ, Beum SH, Lee
YH, Suh JS, Hur H, Kim KS, Kim SH, et al: Prognostic model to
predict survival outcome for curatively resected liposarcoma: A
multi-institutional experience. J Cancer. 7:1174–1180. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Muratori F, Bettini L, Frenos F,
Mondanelli N, Greto D, Livi L, Franchi A, Roselli G, Scorianz M,
Capanna R and Campanacci D: Myxoid liposarcoma: Prognostic factors
and metastatic pattern in a series of 148 patients treated at a
single institution. Int J Surg Oncol. 2018:89287062018.PubMed/NCBI
|
|
42
|
Gronchi A, Hindi N, Cruz J, Blay JY,
Lopez-Pousa A, Italiano A, Alvarez R, Gutierrez A, Rincón I,
Sangalli C, et al: Trabectedin and RAdiotherapy in soft tissue
sarcoma (TRASTS): Results of a phase I study in myxoid liposarcoma
from Spanish (GEIS), Italian (ISG), French (FSG) sarcoma groups.
EClinicalMedicine. 9:35–43. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Aiba H, Yamada S, Mizutani J, Yamamoto N,
Okamoto H, Hayashi K, Kimura H, Takeuchi A, Miwa S, Higuchi T, et
al: Preoperative evaluation of the efficacy of
radio-hyperthermo-chemotherapy for soft tissue sarcoma in a case
series. PLoS One. 13:e01952892018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Vos M, Koseła-Paterczyk H, Rutkowski P,
van Leenders GJLH, Normantowicz M, Lecyk A, Sleijfer S, Verhoef C
and Grünhagen DJ: Differences in recurrence and survival of
extremity liposarcoma subtypes. Eur J Surg Oncol. 44:1391–1397.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Toulmonde M, Bonvalot S, Méeus P, Stoeckle
E, Riou O, Isambert N, Bompas E, Jafari M, Delcambre-Lair C, Saada
E, et al: Retroperitoneal sarcomas: Patterns of care at diagnosis,
prognostic factors and focus on main histological subtypes: A
multicenter analysis of the French sarcoma group. Ann Oncol.
25:735–742. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Salduz A, Alpan B, Valiyev N, Özmen E,
İribaş A, Ağaoğlu F, Bayram A, Bilgiç B and Özger H: Neoadjuvant
radiotherapy for myxoid liposarcomas: Oncologic outcomes and
histopathologic correlations. Acta Orthop Traumatol Turc.
51:355–361. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chao AH, Mayerson JL, Chandawarkar R and
Scharschmidt TJ: Surgical management of soft tissue sarcomas:
Extremity sarcomas. J Surg Oncol. 111:540–545. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Eilber FR and Eckardt J: Surgical
management of soft tissue sarcomas. Semin Oncol. 24:526–533.
1997.PubMed/NCBI
|
|
49
|
Sahu A, Sagar R, Sarkar S and Sagar S:
Psychological effects of amputation: A review of studies from
India. Ind Psychiatry J. 25:4–10. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Rosenberg SA, Tepper J, Glatstein E, Costa
J, Baker A, Brennan M, DeMoss EV, Seipp C, Sindelar WF, Sugarbaker
P and Wesley R: The treatment of soft-tissue sarcomas of the
extremities: Prospective randomized evaluations of (1) limb-sparing
surgery plus radiation therapy compared with amputation and (2) the
role of adjuvant chemotherapy. Ann Surg. 196:305–315. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chung PW, Deheshi BM, Ferguson PC, Wunder
JS, Griffin AM, Catton CN, Bell RS, White LM, Kandel RA and
O'Sullivan B: Radiosensitivity translates into excellent local
control in extremity myxoid liposarcoma: A comparison with other
soft tissue sarcomas. Cancer. 115:3254–3261. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Endo M and Lin PP: Surgical margins in the
management of extremity soft tissue sarcoma. Chin Clin Oncol.
7:372018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Enneking WF, Spanier SS and Goodman MA: A
system for the surgical staging of musculoskeletal sarcoma. Clin
Orthop Relat Res. 106–120. 1980.PubMed/NCBI
|
|
54
|
Skorpil M, Rydén H, Wejde J, Lidbrink E,
Brosjö O and Berglund J: The effect of radiotherapy on fat content
and fatty acids in myxoid liposarcomas quantified by MRI. Magn
Reson Imaging. 43:37–41. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
von Mehren M, Randall RL, Benjamin RS,
Boles S, Bui MM, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane
JM, et al: Soft tissue sarcoma, version 2.2018, NCCN clinical
practice guidelines in oncology. J Natl Compr Canc Netw.
16:536–563. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Pitson G, Robinson P, Wilke D, Kandel RA,
White L, Griffin AM, Bell RS, Catton CN, Wunder JS and O'Sullivan
B: Radiation response: An additional unique signature of myxoid
liposarcoma. Int J Radiat Oncol Biol Phys. 60:522–526. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Chowdhry V, Goldberg S, DeLaney TF, Cote
GM, Chebib I, Kim J, Lozano-Calderón SA and De Amorim Bernstein K:
Myxoid liposarcoma: Treatment outcomes from chemotherapy and
radiation therapy. Sarcoma. 2018:80291572018. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Hatano H, Ogose A, Hotta T, Kawashima H,
Sugita T, Sasamoto R and Endo N: Treatment of myxoid liposarcoma by
marginal or intralesional resection combined with radiotherapy.
Anticancer Res. 23:3045–3049. 2003.PubMed/NCBI
|
|
59
|
Davis AM, O'Sullivan B, Turcotte R, Bell
R, Catton C, Chabot P, Wunder J, Hammond A, Benk V, Kandel R, et
al: Late radiation morbidity following randomization to
preoperative versus postoperative radiotherapy in extremity soft
tissue sarcoma. Radiother Oncol. 75:48–53. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wortman JR, Tirumani SH, Tirumani H,
Shinagare AB, Jagannathan JP, Hornick JL and Ramaiya NH:
Neoadjuvant radiation in primary extremity liposarcoma: Correlation
of MRI features with histopathology. Eur Radiol. 26:1226–1234.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Roberge D, Skamene T, Nahal A, Turcotte
RE, Powell T and Freeman C: Radiological and pathological response
following pre-operative radiotherapy for soft-tissue sarcoma.
Radiother Oncol. 97:404–407. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
de Vreeze RS, de Jong D, Haas RL, Stewart
F and van Coevorden F: Effectiveness of radiotherapy in myxoid
sarcomas is associated with a dense vascular pattern. Int J Radiat
Oncol Biol Phys. 72:1480–1487. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Mullen JT, Hornicek FJ, Harmon DC, Raskin
KA, Chen YL, Szymonifka J, Yeap BY, Choy E, DeLaney TF and Nielsen
GP: Prognostic significance of treatment-induced pathologic
necrosis in extremity and truncal soft tissue sarcoma after
neoadjuvant chemoradiotherapy. Cancer. 120:3676–3682. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Lazarev S, McGee H, Moshier E, Ru M,
Demicco EG and Gupta V: Preoperative vs postoperative radiation
therapy in localized soft tissue sarcoma: Nationwide patterns of
care and trends in utilization. Pract Radiat Oncol. 7:e507–e516.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Zagars GK, Ballo MT, Pisters PW, Pollock
RE, Patel SR and Benjamin RS: Preoperative vs. postoperative
radiation therapy for soft tissue sarcoma: A retrospective
comparative evaluation of disease outcome. Int J Radiat Oncol Biol
Phys. 56:482–488. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
O'sullivan B and Davis AM: A randomized
phase III trial of pre-operative compared to post-operative
radiotherapy in extremity soft tissue sarcoma. Int J Radiat Oncol
Biol Phys. 51:151–152. 2001. View Article : Google Scholar
|
|
67
|
Alektiar K, Brennan M and Singer S: Local
control comparison of IMRT vs. brachytherapy in primary high-grade
extremity Sarcoma. Int J Radiat Oncol Biol Phys. 75:S652009.
View Article : Google Scholar
|
|
68
|
Adjuvant chemotherapy for localised
resectable soft-tissue sarcoma of adults, . Meta-analysis of
individual data. Sarcoma meta-analysis collaboration. Lancet.
350:1647–1654. 1997.PubMed/NCBI
|
|
69
|
Katz D, Boonsirikamchai P, Choi H, Lazar
AJ, Wang WL, Xiao L, Park MS, Ravi V, Benjamin RS and Araujo DM:
Efficacy of first-line doxorubicin and ifosfamide in myxoid
liposarcoma. Clin Sarcoma Res. 2:22012. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Prestwich RJ, Taylor RE and Grimer R:
Metastatic myxoid liposarcoma: Aggressive multimodality management.
Clin Oncol (R Coll Radiol). 17:1302005. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Kerr LT, Donoghue JF, Wilding AL and Johns
TG: Axitinib has antiangiogenic and antitumorigenic activity in
myxoid liposarcoma. Sarcoma. 2016:34846732016. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Gronchi A, Hindi N, Blay JY, Redondo A,
Sanfilippo R, Morosi C, Jurado JC, Fra PL, Martinez-Trufero J,
Morales CMV, et al: Trabectedin and radiotherapy in soft-tissue
sarcoma (TRASTS) study: An international, prospective, phase II
trial in localized myxoid liposarcoma-A collaborative Spanish
(GEIS), Italian (ISG) and French (FSG) group study. J Clin Oncol.
38 (15 Supppl):S115142020. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Chen M and Kirsch DG: Safely combining
trabectedin with radiotherapy to treat myxoid liposarcoma.
EClinicalMedicine. 9:5–6. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Wakely PE Jr, Geisinger KR, Cappellari JO,
Silverman JF and Frable WJ: Fine-needle aspiration cytopathology of
soft tissue: Chondromyxoid and myxoid lesions. Diagn Cytopathol.
12:101–105. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Kilpatrick SE and Ward WG:
Myxofibrosarcoma of soft tissues: Cytomorphologic analysis of a
series. Diagn Cytopathol. 20:6–9. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Asano N, Susa M, Hosaka S, Nakayama R,
Kobayashi E, Takeuchi K, Horiuchi K, Suzuki Y, Anazawa U, Mukai M,
et al: Metastatic patterns of myxoid/round cell liposarcoma: A
review of a 25-year experience. Sarcoma. 2012:3451612012.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Kim HS, Lee J, Yi SY, Jun HJ, Choi YL, Ahn
GH, Seo SW, Lim DH, Ahn YC, Park JO and Kim SJ: Liposarcoma:
Exploration of clinical prognostic factors for risk based
stratification of therapy. BMC Cancer. 9:2052009. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Rydholm A and Rööser B: Surgical margins
for soft-tissue sarcoma. J Bone Joint Surg Am. 69:1074–1078. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Trovik CS: Local recurrence of soft tissue
sarcoma: A Scandinavian sarcoma group project. Acta Orthop Scand.
72:1–27. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Kawaguchi N, Matumoto S and Manabe J: New
method of evaluating the surgical margin and safety margin for
musculoskeletal sarcoma, analysed on the basis of 457 surgical
cases. J Cancer Res Clin Oncol. 121:555–563. 1995. View Article : Google Scholar : PubMed/NCBI
|
